Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,354
New position
Shares Held
100
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#445
of 626 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $150,564,627 across 15 Drug Manufacturers - General names. OGN ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SNY |
Sanofi
|
1,222,650 | $52,158,249 | |
| 2 | MRK |
Merck & Co., Inc.
|
173,781 | $22,330,858 | |
| 3 | ABBV |
AbbVie Inc.
|
85,352 | $21,477,977 | |
| 4 | GSK |
GSK plc
|
277,309 | $14,536,537 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
102,792 | $12,986,741 | |
| 6 | NVS |
Novartis AG
|
73,973 | $11,593,048 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
184,742 | $10,644,834 | |
| 8 | JNJ |
Johnson & Johnson
|
9,373 | $2,380,460 |
All Filings in OGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,354 | 100 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||